Evidence map›Paper›PMID 41737865›Full record

ArticleBioMed research international2026

The Link Between

Olha Obukhova, Mykola Kyrychenko, Ivan Lukavenko, Viktoriia Yu Harbuzova

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Link BetweenBioMed research international · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Olha ObukhovaDepartment of Physiology and Pathophysiology With Medical Biology Course, Medical Institute of the Sumy State University, Sumy, Ukraine, sumdu.edu.ua.ORCID https://orcid.org/0000-0002-2104-8412
Mykola KyrychenkoDepartment of Surgery, Traumatology, Orthopedics and Phthisiology, Medical Institute of the Sumy State University, Sumy, Ukraine, sumdu.edu.ua.ORCID https://orcid.org/0000-0001-9661-3052
Ivan LukavenkoDepartment of Surgery, Traumatology, Orthopedics and Phthisiology, Medical Institute of the Sumy State University, Sumy, Ukraine, sumdu.edu.ua.ORCID https://orcid.org/0000-0003-1302-1698
Viktoriia Yu HarbuzovaDepartment of Physiology and Pathophysiology With Medical Biology Course, Medical Institute of the Sumy State University, Sumy, Ukraine, sumdu.edu.ua.ORCID https://orcid.org/0000-0001-7183-6997

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Aim: We are aimed at examining the potential link between the Materials and Methods: One hundred and six patients with BBD and 221 control subjects were enrolled in this case-control study. PCR-RFLP was used for Results: There was a research relationship between the rs7975232 polymorphism and BPBD and other influencing factors as family history burden, predisposing factors, and blood estradiol levels, smoking, gynecological pathology, hormone intake, goiter, or mastodynia. In individuals younger than 40, heterozygotes have a higher BPBD risk compared with both homozygotes ( Conclusion: Obtained data suggested that rs7975232 polymorphism of the

Indexed as

Breast DiseasesReceptors, CalcitriolAdultCase-Control StudiesEastern European PeopleFemaleGenetic Predisposition to DiseaseHeterozygoteHumansMedical History TakingPolymorphism, Restriction Fragment LengthPolymorphism, Single NucleotideRisk AssessmentRisk FactorsUkraineReceptors, CalcitriolVDR protein, humanbenign mammary dysplasiabenign proliferative breast disease (BPBD)gene polymorphismVDR

Identifiers

PMID41737865
PMCPMC12927896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.